Health
Oxford Coronavirus vaccine update: Phase III trials to conclude by November, mass production expected by 2021 – Times of India
Oxford University backed vaccine is currently in its last stage of testing. The news follows after Russia successfully registered the world’s first COVID-19 vaccine, ‘Sputnik V’ after claiming decent results post completion of phase I.
The announcement also comes after SII head, Adar Poonawallah announced the availability of the vaccine for Indian masses by 2020. In an interview with a media agency recently, he spoke at length, saying:
“We are going to start trials in less than two weeks. The trial is in partnership with ICMR. We will start manufacturing vaccines by the end of August.”
According to revised proposals, the vaccine under the offering, which will be sold and marketed as ‘Covishield’ in India, will involve candid…
-
Noosa News22 hours agoIncrease in extreme weather events poses ‘substantial risk’ to blood supplies, researchers warn
-
Noosa News12 hours agoAustralians tell ABC’s Your Say how they saw the second leaders debate
-
General9 hours agoNT Coalition candidate Lisa Siebert diverges from Jacinta Nampijinpa Price on royal commission call
-
Noosa News10 hours agoBrisbane vs Collingwood live blog: Richmond selects Noah Balta as unbeaten Lions prepare for Magpies test